Racial Disparities in Opioid…Prescription?

Comment

Racial Disparities in Opioid…Prescription?

An article published this past week through the Public Library of Science (PLOS ONE) provided an in-depth look at opioid prescription trends in emergency departments (Singhal, 2016). It has been well documented that minorities are less likely to be prescribed opioids by emergency rooms, with a major 2008 article by Pletcher et al providing some significant data on the subject (Pletcher, 2008). In an attempt to reassess the current literature and view the data through a new lens, Singhal and colleagues specifically looked at whether the opioids were administered in the emergency room or prescribed at discharge (Singhal, 2016). The distinction is a meaningful one, providing insight into provider-patient trust while potentially highlighting the presence of a systemic treatment bias against racial minorities.

Through the analysis of the National Hospital Ambulatory Medical Care Survey (NHAMCS) data collected from 2007-2012, the group found significant racial disparities in both administration and prescription of opioid medication for certain “non-definitive conditions,” including back pain and abdominal pain (Singhal, 2016). Odds ratios, which are statistical measures of an association between an exposure and an outcome, were computed. In this case, the exposure was race, the outcome opioid prescription. It was found that non-Hispanic blacks had 0.67 and 0.58 times the odds of receiving opioids at discharge and in the emergency department, respectively (Singhal, 2016). Both odds ratios were statistically significant, with P values less than 0.05. These ratios, along with the large sample sizes ranging from 3000-10,000 for the significant ailments, speak to the strength of the analysis.

These findings come on the tail of a recent social psychology report out of the University of Virginia by Hoffman et al. which exposed inherent bias against black patients by both laypeople and medical students (Hoffman, 2016). In the later experiment, 222 medical students were presented with patient scenarios and asked about their perception of patient pain, revealing that false beliefs about biological disparity between races led to a “racial bias in pain perception” (Hoffman, 2016). These two articles together highlight the need for further study of, and a focus on counteracting these pervasive biases. However, Singhal’s discussion also highlighted the complexity of assessing doctor-patient interaction and accurately representing the presence of minority bias via discrete data points.

One confounding variable that complicates this assessment is socioeconomic status. A recent New York Times article, which set out to review the Singhal article, points out that in many cases, racial disparity and low socioeconomic status are intertwined, complicating patient care, and the data corresponding to that care (Goodnough, 2016). Despite this confounder, though, the researchers interviewed for the article, including Raymond Tait, a pain researcher in St. Louis, are certain that race plays a role that should not be ignored.

Given this data, it appears as though further inquiry will be necessary to flesh out the problem more fully before meaningful interventions can be executed. The pain management field must self-assess while attempting to create metrics to more specifically explain clinical decision making. One of the major pitfalls of the Singhal paper was the acknowledgement that, even if there is bias, every patient presents differently, complicating the statistical analysis. Additionally, proper control of socioeconomic factors in analyzing racial disparity data should enhance the current picture of minority bias, and potentially point to opinions for intervention.

 

 

References: 

Goodnough, A. (2016, Aug). Finding Good Pain Treatment is Hard. If You’re Not White, It’s Even Harder. New York Times. Retrieved from http://www.nytimes.com/2016/08/10/us/how-race-plays-a-role-in-patients-pain-treatment.html?rref=collection%2Fsectioncollection%2Fhealth&action=click&contentCollection=health&region=stream&module=stream_unit&version=latest&contentPlacement=3&pgtype=sectionfront&_r=1

Hoffman, KM, Trawalter, S, Axt, JR, and Oliver, MN (2016). Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites. PNAS 2016 113 (16) 4296-4301. Retrived from http://www.pnas.org/content/113/16/4296.abstract

Pletcher MJ, Kertesz SG, Kohn MA, Gonzales R (2008).Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA. 2008;299:70–78. Retrived from http://www.ncbi.nlm.nih.gov/pubmed/18167408

Singhal A, Tien Y-Y, Hsia RY (2016). Racial-Ethnic Disparities in Opioid Prescriptions at Emergency Department Visits for Conditions Commonly Associated with Prescription Drug Abuse. PLoS ONE 11(8). Retrived from http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0159224

 

Comment

New test for risk of Alzheimer’s disease

Comment

New test for risk of Alzheimer’s disease

            A new test has been developed to identify those at increased risk for Alzheimer’s disease (Science Bulletin, 2016). The biochip-based blood test was presented at the 68th AACC Annual Scientific Meeting & Clinical Expo in Philadelphia. The biochip, created by Randox Laboratories, will save patients both time and money by conducting multiple tests on the same blood sample and analyzing results in as little as three hours (Nichols, 2016). The biochips were also found to have the same accuracy as a standard DNA test.

            The gene for apolipoprotein is known to be a significant genetic risk factor for a multitude of neurodegenerative diseases, including dementia. Specifically, the E4 variant can increase a person’s risk for developing the disease 8-12 times when inherited from both parents. This new test detects the presence of the protein produced by this gene in a blood sample (Science Bulletin, 2016). According to research scientist Emma C. Harte, Ph.D, of Randox Laboratories, “pairing this test with medical and family history for risk of Alzheimer’s disease,” will greatly improve diagnostic ability as well as personalized medicine.

            Other tests for the disease have been less scientific. With cognitive decline comes progressive loss of senses, smell being the first to go. Researchers at the University of Florida found that those with a confirmed early-stage diagnosis of Alzheimer’s were able to smell a dollop of peanut butter with their right nostril, but not their left (Johnson, 2013). More recently, studies presented at the 2016 Alzheimer’s Association International Conference suggest that a poor score on an odor detection test correlated with subsequent memory loss (Borreli, 2016). These tests may be used in the future for an even cheaper and earlier test for Alzheimer’s disease.

 

(2016). New biochip-based blood test detects elevated risk for Alzheimer’s disease. Science Bulletin. Retrieved from http://sciencebulletin.org/archives/3971.html

Borreli, L. (July 27, 2016). Can't Smell Coffee? Maybe You Have Alzheimer's. Medical Daily. Retrieved from http://www.medicaldaily.com/alzheimers-disease-sniff-test-memory-decline-392885

Johnson, J. (October 9, 2013). Alzheimer's Test: Can You Smell Peanut Butter?. Newser. Retrieved from http://www.newser.com/story/175622/alzheimers-test-can-you-smell-peanut-butter.html

Nichols, H. (August 3, 2016). Alzheimer's: Biochip blood test detects disease risk. Medical News Today. Retrieved from http://www.medicalnewstoday.com/articles/312094.php

Comment

Loss of a Hero in Fertility

Comment

Loss of a Hero in Fertility

Mr. Frank Palopoli, the chemist who developed a drug to treat infertility and subfertility due to anovulatory tendencies died this past Saturday.  He was 94. The drug he helped into existence, Clomiphene citrate, which came to be marketed as Clomid, helps to induce ovulation. Due to it’s safe and effective ability to address infertility through the stimulation of natural hormone production it has been placed on the World Health Organization’s List of Essential Medicines, and remains the only ovulation inducer included. Though the drug was first developed in Palopoli’s lab in 1950 it was took 17 years to come to market, and remains in use today.

It has been shown that the use of clomiphene citrate, in women who experience anovulatory infertility, can increase the chances of pregnancy such that their fertility during treatment can be considered normal. This has allowed many people that previously would have been unable to conceive to do so either naturally or through in vitro fertilization or intrauterine insemination. Up to 80% of anovulatory infertility cases treated with this drug have been shown to be successfully addressed.

More recent research has examined clomiphene citrate as a possible treatment for hypogonadism, the loss of function in the gonads and subsequent decrease in testosterone levels, in men. This alternative use for the drug Mr. Palopoli played an integral role in developing, shows promise and may further extend the impact of his contributions to the collection of drugs used today.

The use of clomiphene citrate and other drugs that induce ovulation has the potential to over stimulate the release of eggs and cause an increase in the rate of multiple pregnancies. Because multiple pregnancies carry a greater risk for both the expectant mother and her children the use of Clomid has also been linked to the abortion debate and the ethics of pregnancy monitoring. The use of this and other fertility therapies remain an important topic in medical ethics.

The group of organic chemists he headed worked under the William S. Merrell Company and contributed to the development of several other agents including triparanol and tamoxifen (researched as possibilities for the treatment of high cholesterol and breast cancer respectively). Clomiphene citrate has now been used by millions of people worldwide.

References: 

Kousta, E. "Modern Use of Clomiphene Citrate in Induction of Ovulation." Human Reproduction Update 3.4 (1997): 359-65. Web.

Roberts, Sam. "Frank Palopoli, Who Aided Fertility With Clomid Drug, Dies at 94." The New York Times. The New York Times, 11 Aug. 2016. Web. 11 Aug. 2016.

Shabsigh, Ahmad, Young Kang, Ridwan Shabsign, Mark Gonzalez, Gary Liberson, Harry Fisch, and Erik Goluboff. "Clomiphene Citrate Effects on Testosterone/Estrogen Ratio in Male Hypogonadism." The Journal of Sexual Medicine 2.5 (2005): 716-21. Web.

"WHO Model Lists of Essential Medicines." World Health Organization. World Health Organization, 1 Apr. 2015. Web. 11 Aug. 2016.

Comment

Analyzing Illegal and Refugee Immigration from a Public Health Perspective

Comment

Analyzing Illegal and Refugee Immigration from a Public Health Perspective

Immigration has been the topic of conversation across the political sphere as of late. The combination of the European migration crisis and the porous southern US border has brought about a fierce debate as to what should be done socially and economically with immigrants. However, one aspect of our nation’s refugee acceptance and illegal immigration issue that has not been discussed as frequently is the impact on public health.

The United States has worked for decades to eradicate some of the diseases that frequently plagued the general population. Through vaccination, new sanitation standards, and updates to dated public health practices, we have eliminated many of the diseases that are still prevalent in other nations. Unfortunately, it is possible that the massive amount of undocumented immigrants entering our country unscreened could cause a spike in previously nonexistent illnesses.

According to multiple reports released over the past few years, including one released on World Migrant Day, the number of tuberculosis, measles, whooping cough, mumps, scarlet fever, and bubonic plague cases has increased. Many healthcare professionals have made a direct link to illegal immigration. Below are a few of the statistics:

 

Tuberculosis: Up 1.7% in 2015 after 23 years of decline

Measles: 667 Cases in 2014 after eradication in 2000

Whooping Cough: 32,971 cases in 2014, 30 times the amount in 1976

Mumps: 688 cases in 2015, after a 99% decrease in prevalence in 1967

 

    All of these diseases have been linked to incoming refugees and undocumented immigrants through the southern border. Many of the camps that house illegal minors are plagued by disease. In 2014, former Congressman Phil Gingrey (R-GA) wrote a scathing letter to Congress about the lack of transparency regarding disease transmission among immigrants. He cited reports of Border Patrol agents contracting diseases from the children. One major news station even reports that tuberculosis is prevalent in multiple camps, citing anonymous reports from healthcare workers employed. Not only is this detrimental to health of Americans, but also the health of the immigrants.  

 

What is the Solution?

    A significant amount of regulation is required in order to halt the spread of these infectious diseases. Currently, refugees are not required to have any vaccines prior to entering the United States. This poses a massive risk to our public health, as the MMR vaccine was directly responsible for eradicating measles after it was required by law. With potential disease carriers entering the U.S. in large numbers, it is almost guaranteed that the public will encounter new illnesses more frequently than before. One of the first steps in preventing further outbreaks is to halt refugee migration and develop a comprehensive screening system for communicable diseases. Additionally, vaccination should be required for all refugees entering the country. The combination of these two processes would eliminate the threat that refugees currently pose to public health.

With respect to the southern border, the U.S. government needs to reduce the number of undocumented immigrants entering the country by a significant amount. There is no way to analyze the health of individuals who have entered and now remain in the country illegally. The only way to prevent diseases from coming up through the southern border is to cut down on illegal immigration.

    Our policy with regard to vaccination and screening significantly differs between migrants and refugees. Many vaccinations are required for United States immigration. This, combined with health screening, has resulted in an extremely small percentage of communicable diseases being brought into our country via legal immigration.

    In short, the massive importation of refugees and illegal aliens into the nation is a very real threat to public health. A comprehensive reform to our refugee health policies and border security is essential to prevent the reoccurrence of deadly communicable diseases. Let’s not decimate the hard work of public health workers before us in their successful efforts to eradicate these illnesses.

 

References:

“Guidelines for Evaluating and Updating Immunizations During the Domestic Medical Examination for Newly Arrived Refugees.” Centers for Disease Control. 11 June, 2015.

“Illegal Alien Minors Spreading TB, Dengue, Swine Flu.” Judicial Watch. 8 July, 2014.

“New Vaccination Criteria for U.S. Immigration.” Centers for Disease Control. 29 March, 2012.

“Six Diseases Return to US as Migration Advocates Celebrate ‘World Refugee Day.’” Breitbart. 19 June, 2016.

 

Comment

It Takes a Village: The Power of Community

Comment

It Takes a Village: The Power of Community

"Imagine a land where you cannot trust the politicians (the most recent president is in jail and the vice president stepped down). Imagine a place where it is expected that any police officer can be bribed and the rule of law can be bought. Who do you turn to during a time of need? In Guatemala, it is the Bomberos."

Comment

Can Traveling Make You a Better Person?

Comment

Can Traveling Make You a Better Person?

"That open-mindedness does not necessitate geographical travel, but rather, traveling into a new perspective. The world is ever-changing and whether one remains in Fargo, North Dakota, or travels the world their whole life, open-mindedness relies on us altering the angles from which we view our world."

Comment

Oh the People You’ll Meet

Comment

Oh the People You’ll Meet

"Perhaps the energy I felt was a reflection of their energy – the energy radiated to redefine HIV and what it means to have the virus or live with its syndrome counterpart."

Comment

AIDS 2016

Comment

AIDS 2016

What if I told you I was a citizen?
A citizen of a universe
A universe like no other
No other place could match it
Match its harmony and freedom
Freedom of speech, sexual orientation and status
Status of being HIV positive or negative,
Black or white, gay, straight or bisexual
Male, female or transgender

What if I told you how life changing it was
It was a hub of information, truth and dreams
Dreams of reaching 90-90-90 goals
Goals where we want to end HIV/AIDS as a pandemic by 2030
2030 – 2016 equals 14 years of dedication
Dedication to advocacy, activism, relentless volunteerism, access
Access to reproductive health commodities, to medication

What if I told you that I was in a room full of people?
People whose passion for fighting this war against HIV/AIDS is unmatched
We matched, yes we did, screaming ‘Sex work is work’
F Word
Proclaiming ‘Treat All’
H Word
Everybody is got a right to be who they are
And yes we said everybody who walks through those doors is entitled to treatment!

I mean all we do is debase each other
I see all we do is discriminate against each other
I’m whisper ‘NO NO NO, lets love each other’
To my colleague, sharing these chairs with one another
On stage Elton John preaching ‘Let’s come together’
Our Benoni girl pleading ‘let’s not have another’
Coz we already had the other
Twice, SA host International AIDS conference

What if I told you I’m still a citizen of that universe?
And that I am of the generation
That will end HIV/AIDS

 

 

Comment